Shimoda Larissa A, Laurie Steven S
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Appl Physiol (1985). 2014 Apr 1;116(7):867-74. doi: 10.1152/japplphysiol.00643.2013. Epub 2013 Dec 12.
In the lung, acute reductions in oxygen lead to hypoxic pulmonary vasoconstriction, whereas prolonged exposures to hypoxia result in sustained vasoconstriction, pulmonary vascular remodeling, and the development of pulmonary hypertension. Data from both human subjects and animal models implicate a role for hypoxia-inducible factors (HIFs), oxygen-sensitive transcription factors, in pulmonary vascular responses to both acute and chronic hypoxia. In this review, we discuss work from our laboratory and others supporting a role for HIF in modulating hypoxic pulmonary vasoconstriction and mediating hypoxia-induced pulmonary hypertension, identify some of the downstream targets of HIF, and assess the potential to pharmacologically target the HIF system.
在肺部,氧气的急性减少会导致缺氧性肺血管收缩,而长期暴露于低氧环境会导致持续性血管收缩、肺血管重塑以及肺动脉高压的发展。来自人类受试者和动物模型的数据表明,缺氧诱导因子(HIFs),即氧敏感转录因子,在肺血管对急性和慢性缺氧的反应中发挥作用。在这篇综述中,我们讨论了来自我们实验室及其他机构的研究工作,这些研究支持HIF在调节缺氧性肺血管收缩和介导缺氧诱导的肺动脉高压中所起的作用,确定了HIF的一些下游靶点,并评估了对HIF系统进行药理学靶向治疗的潜力。